EICHORCondition: Opioid Use Disorder · Sponsor: University of California, Davis
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Main study objective: compare long-term buprenorphine treatment outcomes for patients who start buprenorphine for opioid use disorder (OUD) in the emergency department and are then referred to get outpatient buprenorphine treatment either via telehealth or at an in-person clinic. Researchers will: Compare rates of establishing outpatient OUD treatment, how long patients stay on buprenorphine, and patients' experience with care to determine whether patient experiences and outcomes are better for patients referred to telehealth treatment versus patients patients referred to in-person treatment after they leave the emergency department. Participants will: Be recruited from 3 different hospital emergency departments. Answer questionnaires at baseline and then 1, 3, 6, and 9 months after their initial emergency department visit.
This description comes directly from the study's public registry record.
Meghan Weyrich, MPH · 916-734-7391 · masoulsby@health.ucdavis.edu
Stephen Henry, MD MSc · 916-734-7391 · sghenry@ucdavis.edu
Always discuss trial participation with your own doctor first.
| El Centro Regional Medical Center Emergency Department | El Centro, California, United States | Recruiting |
| University of California Davis Emergency Department | Sacramento, California, United States | Recruiting |
| Olive View - UCLA Medical Center Emegency Department | Sylmar, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06961058